Skip to main content
Journal cover image

Magnetic resonance imaging of Alzheimer's disease.

Publication ,  Journal Article
Xanthakos, S; Krishnan, KR; Kim, DM; Charles, HC
Published in: Prog Neuropsychopharmacol Biol Psychiatry
May 1996

1. Although dementia is caused by a heterogeneous group of diseases and pathologic states, Alzheimer's disease is the largest cause, estimated to account for 50 to 75% of all dementias. 2. Unfortunately, confirmation of Alzheimer's disease (AD) requires postmortem histologic confirmation; clinical diagnosis prior to death remains one of exclusion. 3. A large number of structural and volumetric MRI studies have noted anatomic and structural changes accompanying AD, including variable degrees of general cortical atrophy. 4. A classic feature reported by many MRI studies is hippocampal and temporal lobe atrophy. 5. White matter hyperintensities on MRI are common, especially in late onset AD although their significance is still controversial. 6. This article reviews the contribution of magnetic resonance to imaging the neuropathologic changes of AD, discussing both advantages and limitations, and summarizing the major findings.

Duke Scholars

Published In

Prog Neuropsychopharmacol Biol Psychiatry

DOI

ISSN

0278-5846

Publication Date

May 1996

Volume

20

Issue

4

Start / End Page

597 / 626

Location

England

Related Subject Headings

  • Psychiatry
  • Magnetic Resonance Imaging
  • Humans
  • Brain
  • Atrophy
  • Alzheimer Disease
  • 17 Psychology and Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Xanthakos, S., Krishnan, K. R., Kim, D. M., & Charles, H. C. (1996). Magnetic resonance imaging of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 20(4), 597–626. https://doi.org/10.1016/0278-5846(96)00035-8
Xanthakos, S., K. R. Krishnan, D. M. Kim, and H. C. Charles. “Magnetic resonance imaging of Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry 20, no. 4 (May 1996): 597–626. https://doi.org/10.1016/0278-5846(96)00035-8.
Xanthakos S, Krishnan KR, Kim DM, Charles HC. Magnetic resonance imaging of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996 May;20(4):597–626.
Xanthakos, S., et al. “Magnetic resonance imaging of Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry, vol. 20, no. 4, May 1996, pp. 597–626. Pubmed, doi:10.1016/0278-5846(96)00035-8.
Xanthakos S, Krishnan KR, Kim DM, Charles HC. Magnetic resonance imaging of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996 May;20(4):597–626.
Journal cover image

Published In

Prog Neuropsychopharmacol Biol Psychiatry

DOI

ISSN

0278-5846

Publication Date

May 1996

Volume

20

Issue

4

Start / End Page

597 / 626

Location

England

Related Subject Headings

  • Psychiatry
  • Magnetic Resonance Imaging
  • Humans
  • Brain
  • Atrophy
  • Alzheimer Disease
  • 17 Psychology and Cognitive Sciences
  • 1109 Neurosciences
  • 1103 Clinical Sciences
  • 11 Medical and Health Sciences